US 9303045
5-HT3 receptor antagonists
granted A61KA61K31/19A61K31/5386
Quick answer
US patent 9303045 (5-HT3 receptor antagonists) held by Takeda Pharmaceutical Company Limited expires Mon Mar 31 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Apr 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 31 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/19, A61K31/5386, A61P, A61P1/00